Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 3.2 Billion DKK | 17.99% |
| 2023 | 2.71 Billion DKK | 6.23% |
| 2022 | 2.55 Billion DKK | 2.04% |
| 2021 | 2.5 Billion DKK | 13.16% |
| 2020 | 2.21 Billion DKK | 35.13% |
| 2019 | 1.63 Billion DKK | 5.82% |
| 2018 | 1.54 Billion DKK | 16.23% |
| 2017 | 1.33 Billion DKK | 18.42% |
| 2016 | 1.12 Billion DKK | 22.71% |
| 2015 | 916 Million DKK | 14.79% |
| 2014 | 798 Million DKK | 17.53% |
| 2013 | 679 Million DKK | 17.94% |
| 2012 | 575.7 Million DKK | 5.45% |
| 2011 | 545.97 Million DKK | 6.95% |
| 2010 | 510.48 Million DKK | 10.83% |
| 2009 | 460.58 Million DKK | 9.81% |
| 2008 | 419.43 Million DKK | 12.11% |
| 2007 | 374.11 Million DKK | 1.84% |
| 2006 | 367.35 Million DKK | 7.75% |
| 2005 | 340.93 Million DKK | 11.7% |
| 2004 | 305.22 Million DKK | 8.55% |
| 2003 | 281.17 Million DKK | 3.53% |
| 2002 | 271.59 Million DKK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 739 Million DKK | 3.36% |
| 2024 Q3 | 832 Million DKK | 2.34% |
| 2024 Q2 | 813 Million DKK | 10.01% |
| 2023 Q1 | 662 Million DKK | 2.8% |
| 2023 Q4 | 715 Million DKK | 6.4% |
| 2023 Q3 | 672 Million DKK | 1.2% |
| 2023 FY | 2.71 Billion DKK | 6.23% |
| 2023 Q2 | 664 Million DKK | 0.3% |
| 2022 Q2 | 647 Million DKK | 2.05% |
| 2022 Q1 | 634 Million DKK | 3.93% |
| 2022 Q3 | 629 Million DKK | -2.78% |
| 2022 FY | 2.55 Billion DKK | 2.04% |
| 2022 Q4 | 644 Million DKK | 2.38% |
| 2021 Q2 | 623 Million DKK | -5.89% |
| 2021 Q3 | 608 Million DKK | -2.41% |
| 2021 Q4 | 610 Million DKK | 0.33% |
| 2021 Q1 | 662 Million DKK | 23.74% |
| 2021 FY | 2.5 Billion DKK | 13.16% |
| 2020 Q4 | 535 Million DKK | -12.72% |
| 2020 Q2 | 607 Million DKK | 32.82% |
| 2020 FY | 2.21 Billion DKK | 35.13% |
| 2020 Q1 | 457 Million DKK | 36.01% |
| 2020 Q3 | 613 Million DKK | 0.99% |
| 2019 Q2 | 472 Million DKK | 20.1% |
| 2019 Q1 | 393 Million DKK | -8.6% |
| 2019 FY | 1.63 Billion DKK | 5.82% |
| 2019 Q4 | 336 Million DKK | -22.94% |
| 2019 Q3 | 436 Million DKK | -7.63% |
| 2018 Q1 | 321 Million DKK | -13.71% |
| 2018 FY | 1.54 Billion DKK | 16.23% |
| 2018 Q2 | 394 Million DKK | 22.74% |
| 2018 Q3 | 402 Million DKK | 2.03% |
| 2018 Q4 | 430 Million DKK | 6.97% |
| 2017 Q2 | 341 Million DKK | 24.0% |
| 2017 FY | 1.33 Billion DKK | 18.42% |
| 2017 Q4 | 372 Million DKK | 8.45% |
| 2017 Q3 | 343 Million DKK | 0.59% |
| 2017 Q1 | 275 Million DKK | -20.29% |
| 2016 Q3 | 275 Million DKK | 1.85% |
| 2016 FY | 1.12 Billion DKK | 22.71% |
| 2016 Q4 | 345 Million DKK | 25.45% |
| 2016 Q1 | 234 Million DKK | -13.65% |
| 2016 Q2 | 270 Million DKK | 15.38% |
| 2015 Q3 | 232 Million DKK | 0.43% |
| 2015 Q4 | 271 Million DKK | 16.81% |
| 2015 FY | 916 Million DKK | 14.79% |
| 2015 Q1 | 182 Million DKK | -18.75% |
| 2015 Q2 | 231 Million DKK | 26.92% |
| 2014 Q3 | 205 Million DKK | 5.13% |
| 2014 Q4 | 224 Million DKK | 9.27% |
| 2014 Q1 | 175 Million DKK | -9.98% |
| 2014 Q2 | 195 Million DKK | 11.43% |
| 2014 FY | 798 Million DKK | 17.53% |
| 2013 Q4 | 194.4 Million DKK | 6.75% |
| 2013 FY | 679 Million DKK | 17.94% |
| 2013 Q3 | 182.1 Million DKK | 12.13% |
| 2013 Q2 | 162.4 Million DKK | 15.92% |
| 2013 Q1 | 140.1 Million DKK | -8.26% |
| 2012 Q4 | 152.7 Million DKK | 7.69% |
| 2012 Q1 | 133 Million DKK | -6.12% |
| 2012 FY | 575.7 Million DKK | 5.45% |
| 2012 Q2 | 148.1 Million DKK | 11.35% |
| 2012 Q3 | 141.8 Million DKK | -4.25% |
| 2011 Q2 | 140.2 Million DKK | 6.78% |
| 2011 Q1 | 131.3 Million DKK | -4.92% |
| 2011 Q3 | 132.8 Million DKK | -5.28% |
| 2011 Q4 | 141.67 Million DKK | 6.68% |
| 2011 FY | 545.97 Million DKK | 6.95% |
| 2010 Q1 | 113.1 Million DKK | -7.89% |
| 2010 Q4 | 138.08 Million DKK | 5.17% |
| 2010 FY | 510.48 Million DKK | 10.83% |
| 2010 Q3 | 131.3 Million DKK | 2.58% |
| 2010 Q2 | 128 Million DKK | 13.17% |
| 2009 Q4 | 122.78 Million DKK | 7.43% |
| 2009 FY | 460.58 Million DKK | 9.81% |
| 2009 Q1 | 104.8 Million DKK | 0.0% |
| 2009 Q3 | 114.3 Million DKK | -3.71% |
| 2009 Q2 | 118.7 Million DKK | 13.26% |
| 2008 FY | 419.43 Million DKK | 12.11% |
| 2007 FY | 374.11 Million DKK | 1.84% |
| 2006 FY | 367.35 Million DKK | 7.75% |
| 2005 FY | 340.93 Million DKK | 11.7% |
| 2004 FY | 305.22 Million DKK | 8.55% |
| 2003 FY | 281.17 Million DKK | 3.53% |
| 2002 FY | 271.59 Million DKK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | -7578.582% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 320100100.0% |
| Össur hf. | 485.57 Million USD | -559.221% |
| QHSLab, Inc. | 793.6 Thousand USD | -403248.257% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | -559.221% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | -62101.333% |
| Aurora Spine Corporation | 8.21 Million USD | -38882.903% |
| BrainsWay Ltd. | 23.09 Million USD | -13762.544% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -686238.414% |
| Hamilton Thorne Ltd. | 35.08 Million USD | -9023.973% |
| Vivos Inc. | -6036.00 USD | 53031909.145% |
| Kelyniam Global, Inc. | 2.03 Million USD | -157114.016% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 423099.211% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 1638940.678% |
| Avitar, Inc. | 836.7 Thousand USD | -382473.485% |
| Nanomix Corporation | -69.45 Thousand USD | 4608640.413% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -19017.039% |
| Theraclion SA | -1.08 Million USD | 296383.269% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -353.46 Thousand USD | 905705.93% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -306067.833% |
| Lombard Medical, Inc. | 955 Thousand USD | -335083.246% |
| ALR Technologies Inc. | 4945.00 USD | -64731952.578% |
| Stratec SE | 71.58 Million USD | -4371.379% |
| Vycor Medical, Inc. | 1.31 Million USD | -243201.05% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 532.09 Million USD | -501.581% |
| VMS Rehab Systems, Inc. | -10.44 USD | 30660919640.23% |
| NewCardio, Inc. | 105.1 Thousand USD | -3045483.856% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -8891566.667% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -1191732.54% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -5655976.616% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -544704.697% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -22186.43% |
| IR-Med Inc. | -17 Thousand USD | 18829511.765% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1550629.342% |
| Polarean Imaging plc | 335.48 Thousand USD | -954046.708% |
| United American Healthcare Corporation | -8000.00 USD | 40012600.0% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 24814053.488% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -292483.408% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -181911.716% |
| Urologix, Inc. | 6.09 Million USD | -52435.697% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 1010864.436% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -448566.825% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 18.154% |
| NIOX Group Plc | 28.13 Million USD | -11277.976% |
| Fuse Medical, Inc. | 10.73 Million USD | -29721.579% |
| Broncus Holding Corporation | 7.22 Million USD | -44192.237% |
| Brain Scientific Inc. | 54.32 Thousand USD | -5892214.772% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -400244.188% |
| Health Logic Interactive Inc. | - USD | -Infinity% |